Ventyx Biosciences has shared promising top-line results from a phase 2a study of its investigational central nervous system ...

Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence ...

While AI’s influence is growing across drug discovery, clinical trials and supply chains, it doesn’t provide that ...

Imagine MedEd that thinks, adapts, and delivers unprecedented insights. Better yet, experience if for yourself in our ...

The use of AI in pharma can expedite drug development and manufacturing, enabling novel medicines to get to underserved ...

Galderma’s Nemluvio (nemolizumab) has demonstrated sustained and clinically meaningful improvements in the key signs and ...

AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the US Food and Drug Administration (FDA) ...

The US Food and Drug Administration (FDA) has approved CSL’s Andembry (garadacimab-gxii) to prevent attacks of hereditary ...

AstraZeneca (AZ) has announced promising results from a late-stage study of its C5 complement inhibitor Ultomiris ...

For years, women have been significantly underrepresented in clinical trials, despite making up a large portion of patients ...

Gilead Sciences’ twice-yearly injectable pre-exposure prophylaxis (PrEP) drug has been approved by the US Food and Drug ...